Navigation Links
Less Than Two-Thirds of Surveyed Pharmacy Directors Expect to Reimburse Both Onglyza and Alogliptin Once They are Available for the Treatment of Type 2 Diabetes
Date:2/2/2009

ki, Ph.D., business analyst with HealthLeaders-InterStudy. "Determining the optimal pricing 'sweet spot' will be important to drive uptake of emerging agents."

About Formulary Advantages in Type 2 Diabetes: Impact of Current and Future DPP-IV Inhibitors and GLP-1 Analogues on Advantaged Reimbursement Status for Key Brands

The new Formulary Forum report is based on a survey of 50 pharmacy directors who control national, regional and state-level managed care organizations (MCO). Answers were segmented by type of plan to illustrate variances in strategy by size of plan. The easy-to-use PowerPoint format allows easy visualization of data and easy incorporation of material into presentations.

About Fingertip Formulary

Fingertip Formulary (www.FingertipFormulary.com) offers comprehensive formulary data covering commercial, Medicaid, Medicare and PBM plans, among others, in the United States. The company offers a variety of unique data and marketing solutions that provide access to and insight into formulary data for the pharmaceutical industry, consultants and healthcare providers. Fingertip Formulary is a Decision Resources, Inc. company.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Both HealthLeaders-InterStudy and Fingertip Formulary are Decision Resources, Inc. companies. Please visit De
'/>"/>

SOURCE HealthLeaders-InterStudy; Fingertip Formulary
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. More than two-thirds of sexually active NYC youth use condoms, but other forms of birth control lag
2. Survey: Two-thirds of Illinois public schools provide comprehensive sex education
3. Erbitux Works Well for Two-Thirds of Colon Cancer Patients
4. UNC study: Two-thirds of severe sports injuries to female students due to cheerleading
5. Almost Two-Thirds of Americans Meet Exercise Guidelines
6. Despite Availability of Generic Equivalents, Two-Thirds of Neurologists Will Continue to Prescribe Branded Anti-Epileptic Drugs to Epilepsy Patients
7. World Vision Index of Concern: Half of Americans Surveyed Said They Would Be Willing to Pay More Taxes to Combat AIDS
8. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
9. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
10. Half of Full-Time Employees Surveyed Dont Understand Health Insurance Coverage for Cancer-Related Medical Expenses
11. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... money with comprehensive solution , ... ... Inc., developer of the most popular medical application for ... software suite for the platform – Epocrates® Essentials Deluxe ... Epocrates products on their iPhone and iPod touch devices can ...
(Date:12/15/2009)... based on out-of-pocket costs for beneficiaries based on health status ... ... San Antonio, TX (Vocus) Dec. 14, 2009 -- Physicians ... to be recognized for cost-sharing effectiveness and value in the ... benefits for Medicare beneficiaries. The Medicare Advantage company won ...
(Date:12/15/2009)... manufacturer of Spa, Massage, and Medical tables announces its partnership ... breast comfort system to ease pressure felt while laying face ... ... Freedom, Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, Inc., the ... announced the launch of the Utopian Massage Table with patent ...
(Date:12/15/2009)... announce the release of a new report titled, “Incontinence Devices ... clinical devices used to treat and manage urinary incontinence. ... ... 2009 -- Marketstrat is pleased to announce the release of ... report specifically addresses world markets for clinical devices used to ...
(Date:12/15/2009)... Westchester, Ill. A study in the Dec. ... Sleep Medicine indicates that significant associations exist ... gastrointestinal regurgitation and headaches in young school-aged children. ... that parent-reported insomnia was 3.3 times more likely ... more likely in children with headaches. Nineteen ...
Breaking Medicine News(10 mins):Health News:Epocrates Expands iPhone Offerings with New Premium Content 2Health News:Epocrates Expands iPhone Offerings with New Premium Content 3Health News:Physicians Health Choice Receives Senior Choice Gold Award for 2010 Medicare Plan Benefits 2Health News:Physicians Health Choice Receives Senior Choice Gold Award for 2010 Medicare Plan Benefits 3Health News:Physicians Health Choice Receives Senior Choice Gold Award for 2010 Medicare Plan Benefits 4Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3
... Nov. 14 (HealthDay News) -- A protein that may have ... be a biomarker that indicates severe asthma. And it may ... to new research. , Reporting in the Nov. 15 issue ... University researchers said that people with severe asthma were more ...
... . . . , As the new ... high performance bullet based on technology developed at Oak ... and superior terminal ballistics and is lead-free and safe ... Ohio, the technology is first being made available to ...
... survival remains unclear, scientists say , , WEDNESDAY, Nov. 14 ... longer following an Alzheimer,s diagnosis than white patients, a ... Asian and American Indian descent diagnosed with the disease ... of white Alzheimer,s patients, patients of Hispanic or ...
... - December 31, RICHARDSON, Texas, Nov. 14 ... it will offer three Medicare Part D,prescription drug plans ... Medicare. Medicare beneficiaries in Texas can sign up,for or ... 2008,annual open enrollment period, which begins November 15 and ...
... Inc. announced today that CC Detect(SM), the ... now available from Panacea,Laboratories. CC Detect(SM) is ... identification of individuals with cancer of the ... standard screening methods. Panacea Laboratories,a division of ...
... is,the prepared testimony of NCPA president Steve Giroux before ... behind the counter,availability of certain drugs., "Hello, I ... (NCPA) and a pharmacist from Middleport, New York., ... this public meeting to,explore the public health benefit of ...
Other Medicine News:Health News:Defensive Protein Linked to Asthma 2Health News:Defensive Protein Linked to Asthma 3Health News:Story tips from the Department of Energy's Oak Ridge National Laboratory, Nov. 2007 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 3Health News:Blacks, Hispanics Live Longer With Alzheimer's 4Health News:Blue Cross and Blue Shield of Texas Announces Flexible, Affordable Blue MedicareRx(SM) Medicare Prescription Drug Plans 2Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 2Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 3Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 4Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 5Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 2Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 3Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 4Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 5
(Date:12/15/2009)... University Hospital in Belgium, among the first hospitals ... arc therapy, has carried out its first treatment ... Varian Medical Systems ( VAR). A 56-year-old male ... seconds, over four times faster than possible using ... taken more than five minutes using conventional intensity-modulated ...
(Date:12/15/2009)... Calif., Dec. 15 Masimo (Nasdaq: ... Measure-Through Motion and Low Perfusion pulse oximetry, today ... has been awarded the 2009 Frost & Sullivan ... American Patient Monitoring market. According to Frost & ... Mr. Kiani,s "unprecedented ability in understanding customer requirements, ...
(Date:12/15/2009)... and GLEN ROCK, N.J., Dec. 15 ... of surveyed pharmacy directors expect to cover Pfizer,s ... of chronic pain. Tanezumab, which is expected to ... and is administered intravenously under medical supervision, will ... than a pharmacy benefit according to surveyed pharmacy ...
Breaking Medicine Technology:European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 2European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 3Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6Majority of Surveyed Pharmacy Directors Expect To Cover Pfizer's Tanezumab If It Is Approved for the Treatment of Chronic Pain 2Majority of Surveyed Pharmacy Directors Expect To Cover Pfizer's Tanezumab If It Is Approved for the Treatment of Chronic Pain 3American Society of Plastic Surgeons Annual Meeting Photo Op 59290 1American Society of Plastic Surgeons Annual Meeting Photo Op 59290 2American Society of Plastic Surgeons Annual Meeting Photo Op 59290 3Physicians Gain Visibility Control Over Data With Sage Practice Analytics 59287 1Physicians Gain Visibility Control Over Data With Sage Practice Analytics 59287 2Sudden Cardiac Arrest Association Honors FDNYs Department of Emergency Services for Efforts to Address Sudden Cardiac Arrest 59284 1Sudden Cardiac Arrest Association Honors FDNYs Department of Emergency Services for Efforts to Address Sudden Cardiac Arrest 59284 2
... TAMPA, Fla., Dec. 21 Romark Laboratories, L.C., ... an,$18 million institutional financing with the D.E. Shaw ... enable Romark to advance,development of its lead compound, ... its next-generation thiazolide drug candidates for,the treatment of ...
... to report the,publication of important new research results ... Company,s proprietary compounds. FASgen is a leader in,the ... acid synthase,(FASi), and has conducted extensive research in ... treatment of obesity and fatty,liver disease. The Company ...
Other Medicine Technology:FASgen Announces a New Discovery in Obesity Research 2
The standard of proximal press-fit design. The CLS hip is a straight stem design that is available in 13 sizes in two different neck angles, 135 and 145, to accommodate a wide variety of patient anat...
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Simple straight stem design for the low-demand patient....
Medicine Products: